|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,719.50 JPY | +1.91% |
|
+10.19% | +19.38% |
| 06/01 | Shiseido Early Retirement Program Draws Applicants | MT |
| 06/01 | Shiseido Co Ltd - 257 people applied for early retirement programme at the company, some domestic subsidiaries | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.77 | 2.18 | 1.23 | 0.87 | -0.46 | |||||
Return on Total Capital | 1.17 | 3.27 | 1.83 | 1.21 | -0.62 | |||||
Return On Equity % | -1.78 | 8.36 | 6.3 | 3.82 | -1.44 | |||||
Return on Common Equity | -2.37 | 8.23 | 5.95 | 3.56 | -1.73 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 74.11 | 74.6 | 69.72 | 73.31 | 76.03 | |||||
SG&A Margin | 72.49 | 70.58 | 67.62 | 71.59 | 75.86 | |||||
EBITDA Margin % | 8.95 | 10.76 | 9.39 | 9.6 | 6.67 | |||||
EBITA Margin % | 2.39 | 4.68 | 2.3 | 1.84 | -0.97 | |||||
EBIT Margin % | 1.62 | 4.02 | 2.3 | 1.84 | -0.97 | |||||
Income From Continuing Operations Margin % | -0.99 | 4.34 | 3.52 | 2.48 | -0.94 | |||||
Net Income Margin % | -1.27 | 4.1 | 3.2 | 2.24 | -1.09 | |||||
Net Avail. For Common Margin % | -1.27 | 4.1 | 3.2 | 2.24 | -1.09 | |||||
Normalized Net Income Margin | 0.38 | 2.47 | 1.61 | 1.39 | -0.32 | |||||
Levered Free Cash Flow Margin | 1.92 | 9.41 | -4.95 | 2.79 | -2.39 | |||||
Unlevered Free Cash Flow Margin | 2.16 | 9.55 | -4.8 | 2.98 | -2.13 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.76 | 0.87 | 0.86 | 0.76 | 0.77 | |||||
Fixed Assets Turnover | 2.81 | 2.96 | 2.7 | 2.33 | 2.47 | |||||
Receivables Turnover (Average Receivables) | 5.92 | 7.18 | 6.49 | 5.87 | 6.52 | |||||
Inventory Turnover (Average Inventory) | 1.36 | 1.68 | 2.35 | 1.85 | 1.53 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.46 | 1.36 | 1.35 | 1.28 | 1.2 | |||||
Quick Ratio | 0.83 | 0.83 | 0.78 | 0.69 | 0.63 | |||||
Operating Cash Flow to Current Liabilities | 0.18 | 0.32 | 0.12 | 0.24 | 0.12 | |||||
Days Sales Outstanding (Average Receivables) | 61.85 | 50.8 | 56.28 | 62.22 | 56.16 | |||||
Days Outstanding Inventory (Average Inventory) | 269.54 | 217.78 | 155.12 | 197.2 | 239.09 | |||||
Average Days Payable Outstanding | 139.96 | 112.21 | 160.16 | 250.63 | 243.79 | |||||
Cash Conversion Cycle (Average Days) | 191.43 | 156.37 | 51.24 | 8.79 | 51.45 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 64.02 | 33.66 | 47.49 | 43.88 | 55.47 | |||||
Total Debt / Total Capital | 39.03 | 25.18 | 32.2 | 30.5 | 35.68 | |||||
LT Debt/Equity | 49.1 | 29.18 | 39.54 | 32.65 | 35.89 | |||||
Long-Term Debt / Total Capital | 29.94 | 21.83 | 26.81 | 22.69 | 23.08 | |||||
Total Liabilities / Total Assets | 57.93 | 51.89 | 52.15 | 48.99 | 50.85 | |||||
EBIT / Interest Expense | 4.21 | 17.26 | 9.39 | 5.9 | -2.37 | |||||
EBITDA / Interest Expense | 23.16 | 46.24 | 38.34 | 30.76 | 16.31 | |||||
(EBITDA - Capex) / Interest Expense | 7.32 | 16.15 | 24.47 | 21.96 | 10.17 | |||||
Total Debt / EBITDA | 3.94 | 1.71 | 2.96 | 3.01 | 5.5 | |||||
Net Debt / EBITDA | 2.1 | 0.17 | 1.78 | 1.89 | 4.01 | |||||
Total Debt / (EBITDA - Capex) | 12.45 | 4.91 | 4.65 | 4.21 | 8.81 | |||||
Net Debt / (EBITDA - Capex) | 6.65 | 0.49 | 2.78 | 2.64 | 6.42 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -18.62 | 12.41 | 3.11 | -8.84 | 1.8 | |||||
Gross Profit, 1 Yr. Growth % | -22.15 | 13.15 | -3.63 | -4.14 | 5.58 | |||||
EBITDA, 1 Yr. Growth % | -52.15 | 35.22 | -10.02 | -6.84 | -29.25 | |||||
EBITA, 1 Yr. Growth % | -81.09 | 119.94 | -49.33 | -27.02 | -153.49 | |||||
EBIT, 1 Yr. Growth % | -86.85 | 177.91 | -40.97 | -27.02 | -153.49 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -111.8 | -592.45 | -16.32 | -35.67 | -138.45 | |||||
Net Income, 1 Yr. Growth % | -115.85 | -463.97 | -19.41 | -36.41 | -149.72 | |||||
Normalized Net Income, 1 Yr. Growth % | -94.57 | 633.23 | -32.67 | -21.44 | -123.5 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -115.86 | -463.66 | -19.42 | -36.4 | -149.75 | |||||
Accounts Receivable, 1 Yr. Growth % | -17.09 | 4.25 | 23.79 | -17.79 | 3.08 | |||||
Inventory, 1 Yr. Growth % | -6.11 | -15.45 | -8.92 | 14.28 | 7.26 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 8.35 | 4.8 | 21.04 | -6.99 | -0.77 | |||||
Total Assets, 1 Yr. Growth % | -1.2 | -2.07 | 10.88 | -3.99 | 6.08 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.69 | 63.57 | 5.9 | -1 | -17.63 | |||||
Common Equity, 1 Yr. Growth % | -2.41 | 12.44 | 10.65 | 2.4 | 2.22 | |||||
Cash From Operations, 1 Yr. Growth % | -15.24 | 91.88 | -61.97 | 90.49 | -45.63 | |||||
Capital Expenditures, 1 Yr. Growth % | -38.87 | 28.68 | -49.96 | -26.42 | -6.91 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -169.79 | 449.99 | -154.28 | -151.34 | -187.14 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -186.1 | 396.18 | -151.8 | -156.68 | -172.72 | |||||
Dividend Per Share, 1 Yr. Growth % | -33.33 | 25 | 0 | 20 | -33.33 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -8.29 | -4.35 | 7.66 | -3.05 | -3.66 | |||||
Gross Profit, 2 Yr. CAGR % | -11.07 | -6.15 | 4.42 | -3.89 | 0.6 | |||||
EBITDA, 2 Yr. CAGR % | -26.41 | -19.57 | 10.3 | -8.45 | -18.82 | |||||
EBITA, 2 Yr. CAGR % | -55.29 | -35.52 | 5.57 | -39.19 | -37.52 | |||||
EBIT, 2 Yr. CAGR % | -62.84 | -39.56 | 28.09 | -34.36 | -37.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -62.51 | -23.78 | 103 | -26.63 | -50.27 | |||||
Net Income, 2 Yr. CAGR % | -56.42 | -24.05 | 71.27 | -28.41 | -43.77 | |||||
Normalized Net Income, 2 Yr. CAGR % | -76.83 | -36.93 | 122.19 | -27.27 | -57.03 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -56.4 | -24.04 | 71.19 | -28.41 | -43.75 | |||||
Accounts Receivable, 2 Yr. CAGR % | -7.39 | -7.03 | 13.6 | 0.88 | -7.94 | |||||
Inventory, 2 Yr. CAGR % | 6.54 | -10.91 | -12.24 | 2.03 | 10.72 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 20.42 | 6.56 | 12.63 | 6.11 | -3.93 | |||||
Total Assets, 2 Yr. CAGR % | 9.21 | -1.63 | 4.21 | 3.18 | 0.92 | |||||
Tangible Book Value, 2 Yr. CAGR % | -7.27 | 26.81 | 31.61 | 2.39 | -9.7 | |||||
Common Equity, 2 Yr. CAGR % | 3.94 | 4.75 | 11.54 | 6.44 | 2.31 | |||||
Cash From Operations, 2 Yr. CAGR % | -16.83 | 27.53 | -14.58 | -14.89 | 1.77 | |||||
Capital Expenditures, 2 Yr. CAGR % | -16.38 | -11.31 | -19.76 | -39.32 | -17.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -9.31 | 95.91 | 72.78 | -47.21 | -33.11 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -6.67 | 106.69 | 60.32 | -45.81 | -35.8 | |||||
Dividend Per Share, 2 Yr. CAGR % | -5.72 | -8.71 | 11.8 | 9.54 | -10.56 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -2.87 | -1.85 | -1.93 | 1.85 | -1.46 | |||||
Gross Profit, 3 Yr. CAGR % | -4.1 | -3.63 | -5.32 | 1.49 | -0.83 | |||||
EBITDA, 3 Yr. CAGR % | -12.8 | -9.87 | -16.5 | 4.26 | -15.99 | |||||
EBITA, 3 Yr. CAGR % | -36.16 | -23.96 | -40.49 | -6.66 | -41.73 | |||||
EBIT, 3 Yr. CAGR % | -42.91 | -27.33 | -40.03 | 6.19 | -38.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -28.88 | -11.55 | -21.37 | 38.4 | -40.85 | |||||
Net Income, 3 Yr. CAGR % | -19.97 | -11.59 | -22.53 | 23.1 | -36.6 | |||||
Normalized Net Income, 3 Yr. CAGR % | -58.17 | -26.72 | -35.54 | 57.11 | -50.09 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -19.93 | -11.58 | -22.53 | 23.06 | -36.59 | |||||
Accounts Receivable, 3 Yr. CAGR % | -4.17 | -3.66 | 2.28 | 1.99 | 1.61 | |||||
Inventory, 3 Yr. CAGR % | 9.37 | -1.36 | -10.25 | -4.17 | 3.74 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 29.05 | 14.97 | 11.18 | 5.67 | 3.76 | |||||
Total Assets, 3 Yr. CAGR % | 8.25 | 5.32 | 2.37 | 1.4 | 4.14 | |||||
Tangible Book Value, 3 Yr. CAGR % | -1.51 | 12.04 | 19.42 | 19.7 | -4.77 | |||||
Common Equity, 3 Yr. CAGR % | 4.61 | 6.7 | 6.68 | 8.41 | 5.02 | |||||
Cash From Operations, 3 Yr. CAGR % | -12.44 | 9.9 | -14.8 | 11.6 | -26.7 | |||||
Capital Expenditures, 3 Yr. CAGR % | 16.1 | -3.46 | -26.72 | -22.04 | -30.02 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -34.34 | 65.38 | 27.72 | 15.29 | -37.61 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -32.23 | 62.89 | 30.31 | 13.36 | -40.23 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.3 | 3.57 | -5.9 | 14.47 | -7.17 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -1.34 | 4.01 | 1.21 | -2.33 | -2.63 | |||||
Gross Profit, 5 Yr. CAGR % | -1.35 | 3.74 | -0.78 | -3.73 | -2.99 | |||||
EBITDA, 5 Yr. CAGR % | -2.95 | 7.9 | -4.2 | -9.3 | -17.44 | |||||
EBITA, 5 Yr. CAGR % | -16.22 | 3.05 | -21.93 | -30.46 | -39.32 | |||||
EBIT, 5 Yr. CAGR % | -20.28 | 2.49 | -21.13 | -30.23 | -39.04 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -22.18 | 5.77 | 8.19 | -17.92 | -34.53 | |||||
Net Income, 5 Yr. CAGR % | -16.69 | 5.74 | 8.5 | -18.75 | -31.85 | |||||
Normalized Net Income, 5 Yr. CAGR % | -33.12 | 3.6 | -18.42 | -26.94 | -45.19 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -16.69 | 5.74 | 8.51 | -18.74 | -31.84 | |||||
Accounts Receivable, 5 Yr. CAGR % | 2.38 | 1.75 | 2.58 | -1.87 | -1.94 | |||||
Inventory, 5 Yr. CAGR % | 9.93 | 4.44 | 0.15 | -0.02 | -2.39 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 20.49 | 18 | 22.21 | 11.34 | 4.87 | |||||
Total Assets, 5 Yr. CAGR % | 8.29 | 4.51 | 6.61 | 4.46 | 1.79 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.11 | 22.07 | 10.6 | 8.08 | 6.79 | |||||
Common Equity, 5 Yr. CAGR % | 4.35 | 6.76 | 7.33 | 6.6 | 4.91 | |||||
Cash From Operations, 5 Yr. CAGR % | -4.52 | 15.76 | -13.3 | -0.78 | -8.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | 20.07 | 18.25 | 0.15 | -19.82 | -23.06 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | 54.64 | -3.31 | 4.74 | -1.4 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | 53.72 | -4.36 | 4.88 | -1.82 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.92 | 20.11 | 12.7 | 5.92 | -7.79 |
- Stock Market
- Equities
- 4911 Stock
- Financials Shiseido Company, Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















